SCHEMBL8817044

SCHEMBL8817044

CCCC(c1ccccc1)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 1/20 0.54
LMNA P02545 3/20 0.49
ALDH1A1 P00352 3/20 0.49
MAPT P10636 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
KMT2A Q03164 2/20 0.48
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
CA2 P00918 1/20 0.46
NPY2R P49146 1/20 0.45
NPSR1 Q6W5P4 2/20 0.44
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
MMP2 P08253 2/20 0.43
MMP3 P08254 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16690471 0.90 MMP13 (0.55) MMP13LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL7599905 0.86 MMP13 (0.52) MMP13LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL27993045 0.82 MMP13 (0.49) MMP13LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL17280850 0.82 MMP13 (0.49) MMP13LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL14036499 0.80 MAPT (0.46) MMP13LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL6390519 0.80 MMP13 (0.52) MMP13ALDH1A1MAPTSMN1; SMN2RAB9A
SCHEMBL1899005 0.79 ALDH1A1 (0.48) MMP13LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL23720089 0.77 MMP13 (0.50) MMP13ALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL10899009 0.77 SMN1; SMN2 (0.44) MMP13LMNASMN1; SMN2
SCHEMBL29160363 0.76 ALDH1A1 (0.79) LMNAALDH1A1MAPTSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997023215-A1 2-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE-SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed